10 Biggest Price Target Changes For Wednesday - Aramark (NYSE:ARMK), Bausch Health Companies (NYSE:BHC)

Raymond James raised Haemonetics Corporation HAE price target from $110 to $150. Haemonetics shares closed at $131.24 on Tuesday.
Sandler O'Neill lowered the price target for GreenSky, Inc. GSKY from $14 to $7. GreenSky shares closed at $6.81 on Tuesday.
KeyBanc cut the price target for Colfax Corporation CFX from $40 to $37. Colfax shares closed at $28.45 on Tuesday.
JP Morgan lowered the price target on International Flavors & Fragrances Inc. IFF from $127 to $125. International Flavors shares closed at $118.91 on Tuesday.
Baird boosted the price target for Aramark ARMK from $38 to $40. Aramark shares closed at $36.52 on Tuesday.
RBC Capital lowered the price target for NCS Multistage Holdings, Inc. NCSM from $6 to $3. NCS Multistage shares closed at $2.33 on Tuesday.
Raymond James cut the price target for Benefitfocus, Inc. BNFT from $50 to $30. Benefitfocus shares closed at $23.49 on Tuesday.
Buckingham Research boosted the price target on Builders FirstSource, Inc. BLDR from $17 to $21. Builders FirstSource closed at $18.98 on Tuesday.
H.C. Wainwright raised Bausch Health Companies Inc. BHC price target from $50 to $54. Bausch Health shares closed at $22.58 on Tuesday.
Imperial Capital cut Cimarex Energy Co. XEC price target from $58 to $51. Cimarex Energy shares closed at $43.95 on Tuesday.